Home > G. Tumoral pathology > BAP1-mutated mesothelioma
BAP1-mutated mesothelioma
Friday 17 May 2013
See also
BAP1-mutated tumors
Open references
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. Carbone M, Ferris LK, Baumann F, Napolitano A, Lum CA, Flores EG, Gaudino G, Powers A, Bryant-Greenwood P, Krausz T, Hyjek E, Tate R, Friedberg J, Weigel T, Pass HI, Yang H. J Transl Med. 2012 Aug 30;10:179. doi : 10.1186/1479-5876-10-179 PMID: 22935333 [Free]
References
Molecular pathogenesis of malignant mesothelioma. Sekido Y. Carcinogenesis. 2013 May 14. PMID: 23677068
Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation. Ribeiro C, Campelos S, Moura CS, Machado JC, Justino A, Parente B. Ann Oncol. 2013 Apr 12. PMID: 23585512
New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment. Ladanyi M, Zauderer MG, Krug LM, Ito T, McMillan R, Bott M, Giancotti F. Clin Cancer Res. 2012 Sep 1;18(17):4485-90. doi : 10.1158/1078-0432.CCR-11-2375 PMID: 22825583
Germline BAP1 mutations predispose to malignant mesothelioma. Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M. Nat Genet. 2011 Aug 28;43(10):1022-5. doi : 10.1038/ng.912 PMID: 21874000